These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 25316229)

  • 1. Correlation of Th17 cells and CD4⁺CD25⁺ regulatory T cells with clinical parameters in patients with systemic sclerosis.
    Jiang N; Li M; Zeng X
    Chin Med J (Engl); 2014; 127(20):3557-61. PubMed ID: 25316229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of CD4(+)CD25(+)FoxP3(+) T cells in systemic sclerosis patients contribute to the secretion of IL-17 and immunosuppression dysfunction.
    Liu X; Gao N; Li M; Xu D; Hou Y; Wang Q; Zhang G; Sun Q; Zhang H; Zeng X
    PLoS One; 2013; 8(6):e64531. PubMed ID: 23776439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated and resting regulatory T cell exhaustion concurs with high levels of interleukin-22 expression in systemic sclerosis lesions.
    Mathian A; Parizot C; Dorgham K; Trad S; Arnaud L; Larsen M; Miyara M; Hié M; Piette JC; Frances C; Yssel H; Amoura Z; Gorochov G
    Ann Rheum Dis; 2012 Jul; 71(7):1227-34. PubMed ID: 22696687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of Runx1 and lowered proportion of Foxp3⁺ CD25⁺ CD4⁺ regulatory T cells in systemic sclerosis.
    Kataoka H; Yasuda S; Fukaya S; Oku K; Horita T; Atsumi T; Koike T
    Mod Rheumatol; 2015 Jan; 25(1):90-5. PubMed ID: 24716598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher levels of serum interleukin-35 are associated with the severity of pulmonary fibrosis and Th2 responses in patients with systemic sclerosis.
    Tang J; Lei L; Pan J; Zhao C; Wen J
    Rheumatol Int; 2018 Aug; 38(8):1511-1519. PubMed ID: 29846790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease Manifestation and Inflammatory Activity as Modulators of Th17/Treg Balance and RORC/FoxP3 Methylation in Systemic Sclerosis.
    Almanzar G; Klein M; Schmalzing M; Hilligardt D; El Hajj N; Kneitz H; Wild V; Rosenwald A; Benoit S; Hamm H; Tony HP; Haaf T; Goebeler M; Prelog M
    Int Arch Allergy Immunol; 2016; 171(2):141-154. PubMed ID: 27902985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
    Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
    Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered Th17 cells and Th17/regulatory T-cell ratios indicate the subsequent conversion from undifferentiated connective tissue disease to definitive systemic autoimmune disorders.
    Szodoray P; Nakken B; Barath S; Csipo I; Nagy G; El-Hage F; Osnes LT; Szegedi G; Bodolay E
    Hum Immunol; 2013 Dec; 74(12):1510-8. PubMed ID: 23974054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory T cells (CD4(+)CD25(bright)FoxP3(+)) expansion in systemic sclerosis correlates with disease activity and severity.
    Slobodin G; Ahmad MS; Rosner I; Peri R; Rozenbaum M; Kessel A; Toubi E; Odeh M
    Cell Immunol; 2010; 261(2):77-80. PubMed ID: 20096404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis.
    Fenoglio D; Battaglia F; Parodi A; Stringara S; Negrini S; Panico N; Rizzi M; Kalli F; Conteduca G; Ghio M; De Palma R; Indiveri F; Filaci G
    Clin Immunol; 2011 Jun; 139(3):249-57. PubMed ID: 21419712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-17 and interleukin-23: importance in the pathogenesis of lung impairment in patients with systemic sclerosis.
    Olewicz-Gawlik A; Danczak-Pazdrowska A; Kuznar-Kaminska B; Gornowicz-Porowska J; Katulska K; Trzybulska D; Batura-Gabryel H; Silny W; Poplawski D; Hrycaj P
    Int J Rheum Dis; 2014 Jul; 17(6):664-70. PubMed ID: 24467649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA hypermethylation of the forkhead box protein 3 (FOXP3) promoter in CD4+ T cells of patients with systemic sclerosis.
    Wang YY; Wang Q; Sun XH; Liu RZ; Shu Y; Kanekura T; Huang JH; Li YP; Wang JC; Zhao M; Lu QJ; Xiao R
    Br J Dermatol; 2014 Jul; 171(1):39-47. PubMed ID: 24641670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of thalidomide on Th17, Treg cells and TGF-β1/Smad3 pathway in a mouse model of systemic sclerosis.
    Lu Y; Zhao C; Lei L; Tao Z; Zheng L; Wen J; Li X
    Int J Rheum Dis; 2020 Mar; 23(3):406-419. PubMed ID: 31840939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of cellular immunity in systemic sclerosis pathogenesis: update on CD4+T cells population studies.
    Beşliu AN; Bănică LM; Lonescu R; Predeţeanu D; Stăvaru C; Marica CM; Chiţonu C; Pistol G; Stefănescu M; Matache C
    Roum Arch Microbiol Immunol; 2009; 68(1):5-13. PubMed ID: 19507621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin.
    Bovenschen HJ; van de Kerkhof PC; van Erp PE; Woestenenk R; Joosten I; Koenen HJ
    J Invest Dermatol; 2011 Sep; 131(9):1853-60. PubMed ID: 21654831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression.
    Radstake TR; van Bon L; Broen J; Wenink M; Santegoets K; Deng Y; Hussaini A; Simms R; Cruikshank WW; Lafyatis R
    PLoS One; 2009 Jun; 4(6):e5981. PubMed ID: 19543397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea.
    Antiga E; Quaglino P; Bellandi S; Volpi W; Del Bianco E; Comessatti A; Osella-Abate S; De Simone C; Marzano A; Bernengo MG; Fabbri P; Caproni M
    Br J Dermatol; 2010 May; 162(5):1056-63. PubMed ID: 20105169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma.
    Klein S; Kretz CC; Ruland V; Stumpf C; Haust M; Hartschuh W; Hartmann M; Enk A; Suri-Payer E; Oberle N; Krammer PH; Kuhn A
    Ann Rheum Dis; 2011 Aug; 70(8):1475-81. PubMed ID: 21097800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into CD4(+) T cell abnormalities in systemic sclerosis.
    Liu M; Wu W; Sun X; Yang J; Xu J; Fu W; Li M
    Cytokine Growth Factor Rev; 2016 Apr; 28():31-6. PubMed ID: 26724976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treg depletion attenuates irradiation-induced pulmonary fibrosis by reducing fibrocyte accumulation, inducing Th17 response, and shifting IFN-γ, IL-12/IL-4, IL-5 balance.
    Xiong S; Guo R; Yang Z; Xu L; Du L; Li R; Xiao F; Wang Q; Zhu M; Pan X
    Immunobiology; 2015 Nov; 220(11):1284-91. PubMed ID: 26224246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.